Cardiotoxicity of fda-approved immune checkpoint inhibitors: A rare but serious adverse event

Abdulrazzak Zarifa, Mohammed Salih, Juan Lopez-Mattei, Hun Ju Lee, Cezar Iliescu, Saamir Hassan, Nicolas Palaskas, Jean Bernard Durand, Elie Mouhayar, Joseph Kim, Peter Kim

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiotoxicity of fda-approved immune checkpoint inhibitors: A rare but serious adverse event'. Together they form a unique fingerprint.

Medicine & Life Sciences